Prevalence and risk factors of cholelithiasis in Amol city, Northern Iran: A population based study

Archives of Iranian Medicine

Volumn 17, Issue 11, 2014, Pages 750-754

  Zamani, Farhad ^a   Sohrabi, Masoudreza ^a   Alipour, Abbas ^b   Motamed, Nima ^a   Saeedian, Fateme Sima ^a   Pirzad, Reza ^b   Abedi, Khadijeh ^b   Maadi, Mansoreh ^a   Ajdarkosh, Hossein ^a   Hemmasi, Gholamreza ^a   Khonsari, Mahmood ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholelithiasis; Epidemiology; Iran; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLELITHIASIS; DIASTOLIC HYPERTENSION; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; IRAN; MALE; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; SYSTOLIC HYPERTENSION; HEALTH; MIDDLE AGED;

ADULT; CHOLELITHIASIS; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; URBAN HEALTH;

EID: 84908373011     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007; 261(6): 529-542.
2. Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol. 2012; 4(2): 18-34.
3. Park JH, Kim TN, Lee SH. The prevalence and risk factors of gallstones in Korean patients with liver cirrhosis. Hepatogastroenterol-ogy. 2013; 60: 123
4. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010; 39(2): 157-169.
5. Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, et al. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol. 2008; 14(34): 5282-5289.
6. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab. 2004; 89(6): 2522-2525.
7. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012; 6(2): 172-187.
8. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005; 7(2): 132-140.
9. Abu-Eshy SA, Mahfouz AA, Badr A, El Gamal MN, Al-Shehri MY, Salati MI, et al. Prevalence and risk factors of gallstone disease in a high altitude Saudi population. East Mediterr Health J. 2007; 13(4): 794-802.
10. Toosi FS, Ehsanbakhsh AR Tavakoli MR. Asymptomatic gallstones and related risk factors in Iran. Hepatogastroenterology. 2011; 58(109): 1123-1126.
11. Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011; 11: 111.
12. Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Car-bonnel F, et al. Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. QMAJ. 2013; 185(7): 555-561.
13. Hou L, Shu XO, Gao YT, Ji BT, Weiss JM, Yang G, et al. Anthropo-metric measurements, physical activity, and the risk of symptomatic gallstone disease in Chinese women. Ann Epidemiol. 2009; 19(5): 344-350.
14. Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol. 2006 Nov;21(11):1737-1743.
15. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012; 125(1): e2-e220.
16. Straub BK, Schirmacher P. Pathology and biopsy assessment of nonalcoholic fatty liver disease. DigDis. 2010; 28(1): 197-202.
17. Massarrat S. Prevalence of gallstone disease in Iran. J Gastroenterol Hepatol. 2001; 16(5): 564-567.
18. Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012; 18(31): 4215-4220.
19. Novacek G. Gender and gallstone disease. Wien Med Wochenschr. 2006; 156(19-20): 527-533.
20. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, et al. Effect of estrogen therapy on gallbladder disease. JAMA. 2005; 293(3): 330-339.
21. Dhiman RK, Chawla YK. Is there a link between oestrogen therapy and gallbladder disease? Expert Opin Drug Saf. 2006; 5(1): 117-129.
22. Etminan M, Delaney JA, Bressler B, Brophy JM. Oral contraceptives and the risk of gallbladder disease: a comparative safety study. CMIAJ. 2011; 183(8): 899-904.
23. Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol. 2000; 12(12): 1347-1352.
24. Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A men-delian randomization study. Hepatology. 2013; 58(6): 2133-2141. DOI: 10.1002/hep.26563. Epub 2013 Oct 11.
25. Takahashi Y, Yamamichi N, Shimamoto T, Mochizuki S, Fujishiro M, Takeuchi C, et al. Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan. J Gastro-enterol. 2013; 49(5): 882-889. DOI: 10.1007/s00535-013-0832-z. Epub 2013 Jun 5.
26. Liew PL, Wang W, Lee YC, Huang MT, Lin YC, Lee WJ. Gallbladder disease among obese patients in Taiwan. Obes Surg. 2007; 17(3): 383-390.
27. Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigo-lon A, et al. Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis. 2004; 36(2): 130-134.
28. Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006; 20(6): 981-996.
29. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology. 1990; 99(3): 843-849.
30. Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol. 2013; 108(6): 952-958.
31. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol. 2005; 20(8): 1176-1184.
32. Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, et al. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing. 1998; 27(4): 437-441.
33. Acalovschi M, Buzas C, Radu C, Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat. 2009; 16(12): 860-866.
34. Liu CM, Tung TH, Chou P, Chen VT, Hsu CT, Chien WS, et al. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol. 2006; 12(8): 1281-1286.
35. Unisa S, Jagannath P, Dhir V, Khandelwal C, Sarangi L, Roy TK. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford). 2011; 13(2): 117-125.